Showing results (381-390 of 537) with videos related to
Sort By:
Pageof 54
Journal of Neurology, Neurosurgery, and Psychiatry|April 21, 2019
Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysisPeter J Goadsby, David W Dodick, James M Martinez, et al.European Journal of Neurology|March 18, 2022
Efficacy and quality-of-life improvements with fremanezumab treatment in patients with difficult-to-treat migraine with associated neurological dysfunctionChristian Lampl, Alan M Rapoport, Joshua M Cohen, et al.The Journal of Headache and Pain|March 16, 2007
Cephalalgiaphobia: a possible specific phobia of illnessMario F P Peres, Juliane P P Mercante, Vera Z Guendler, et al.Headache|January 1, 2020
Neuroimaging for Migraine: The American Headache Society Systematic Review and Evidence-Based GuidelineRandolph W Evans, Rebecca C Burch, Benjamin M Frishberg, et al.Headache|October 21, 2018
Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender DifferencesRichard B Lipton, Sagar Munjal, Aftab Alam, et al.The Journal of Headache and Pain|May 26, 2018
Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) studyTodd J Schwedt, Aftab Alam, Michael L Reed, et al.Cephalalgia : an International Journal of Headache|November 4, 2020
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraineDavid W Dodick, Erin G Doty, Sheena K Aurora, et al.Headache|May 22, 2021
Patient experience of telemedicine for headache care during the COVID-19 pandemic: An American Migraine Foundation survey studyChia-Chun Chiang, Rashmi Halker Singh, Nim Lalvani, et al.JAMA Neurology|December 20, 2021
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical TrialsMessoud Ashina, Peter J Goadsby, David W Dodick, et al.Headache|August 15, 2019
Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment StudyRichard B Lipton, Sagar Munjal, Dawn C Buse, et al.Pageof 54